Parataxis is making waves by acquiring Bridge Biotherapeutics in a strategic move to launch a Bitcoin treasury in Korea. This acquisition marks a significant step in expanding Bitcoin’s reach and promoting its adoption within the Korean market. Stakeholders should consider the implications of this partnership, as it showcases increasing corporate interest in the cryptocurrency space.